Immunization Programs -- Guideline -- United States : Priorities for the national vaccine plan / Committee on Review of Priorities in the National Vaccine Plan, Board on Population Health and Public Health Practice, Institute of Medicine
Immunization Programs -- organization & administration -- United States : Initial guidance for an update of the National Vaccine Plan : a letter report to the National Vaccine Program Office / Committee on the Review of Priorities in the National Vaccine Plan, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies
Immunization -- standards : The childhood immunization schedule and safety : stakeholder concerns, scientific evidence, and future studies / Committee on the Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies
Immunization -- Study and teaching -- Australia. : National guidelines for immunisation education for registered nurses & midwives : a guide for course assessors, educators & training organisations
Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow)
An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993
An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993
Immuno-ordinateur. : Artificial immune systems : 4th international conference, ICARIS 2005, Banff, Alberta, Canada, August 14-17, 2005 : proceedings / Christian Jacob [and others] (eds.)
2005
1
Immuno-ordinateurs. : Artificial immune systems : 5th international conference, ICARIS 2006, Oeiras, Portugal, September 4-6, 2006 : proceedings / Hugues Bersini, Jorge Carneiro (eds.)
A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance
Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens
--subdivision Immunological aspects under physiological topics and individual diseases and types of diseases, e.g. Aging--Immunological aspects; Cancer--Immunological aspects; and subdivision Immunology under individual animals and groups of animals, individual chemicals and groups of chemicals, and individual organs and regions of the body, e.g. Fishes--Immunology; Copper--Immunology; Insulin--Immunology; Heart--Immunology
Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes
Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes
